| 000 | 01248 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513195906.0 | ||
| 264 | 0 | _c19991221 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0271-0749 | ||
| 024 | 7 |
_a10.1097/00004714-199912000-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJungerman, T | |
| 245 | 0 | 0 |
_aDeprenyl augmentation for treating negative symptoms of schizophrenia: a double-blind, controlled study. _h[electronic resource] |
| 260 |
_bJournal of clinical psychopharmacology _cDec 1999 |
||
| 300 |
_a522-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aPlacebo Effect |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aSelegiline _xtherapeutic use |
| 700 | 1 | _aRabinowitz, D | |
| 700 | 1 | _aKlein, E | |
| 773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 19 _gno. 6 _gp. 522-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004714-199912000-00006 _zAvailable from publisher's website |
| 999 |
_c10543460 _d10543460 |
||